Compare $GTHP vs $HSCS | Chartloom

Compare

$GTHP vs $HSCS

Guided Therapeutics Inc · HeartSciences Inc

GTHP

Guided Therapeutics Inc

HSCS

HeartSciences Inc

Compare $GTHP vs $HSCS

Comparing Guided Therapeutics Inc and HeartSciences Inc

GTHPGuided Therapeutics Inc

HSCSHeartSciences Inc

GTHPGuided Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

450.8%

YTD performance

-63.0%

52W performance

-20.0%

FCF yield

-7.8%

HSCSHeartSciences Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

73.69x

Rev growth (TTM)

-28.6%

YTD performance

1.3%

52W performance

-14.5%

FCF yield

-57.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GTHP

HSCS

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

HSCS

HeartSciences Inc

Market Cap

GTHP$19M

HSCS$12M

Enterprise Value

GTHP$21M

HSCS$16M

Price

GTHP$0.20

HSCS$3.18

P/E Ratio

GTHPN/A

HSCSN/A

P/S Ratio

GTHP29.70x

HSCS2,756.00x

EV/Sales

GTHP32.92x

HSCS3,576.69x

EV/EBITDA

GTHP0.00x

HSCS0.00x

P/B Ratio

GTHP33.42x

HSCS91.31x

P/FCF Ratio

GTHPN/A

HSCSN/A

EV/FCF

GTHP-14.21x

HSCS-2.26x

PEG Ratio

GTHPN/A

HSCSN/A

Forward P/E (NTM)

GTHPN/A

HSCSN/A

Forward P/S (NTM)

GTHPN/A

HSCS73.69x

Revenue (TTM)

GTHP$650K

HSCS$5K

Revenue Growth (YoY)

GTHP450.8%

HSCS-28.6%

Forward Rev Growth

GTHP0.0%

HSCS781.1%

Gross Margin (TTM)

GTHP75.8%

HSCS60.0%

Operating Margin (TTM)

GTHP0.0%

HSCS0.0%

EBITDA Margin (TTM)

GTHP-336.2%

HSCS-210017.8%

Net Margin (TTM)

GTHP-560.6%

HSCS-227982.2%

FCF Margin (TTM)

GTHP-231.7%

HSCS-158133.3%

Net Income (TTM)

GTHP$-4M

HSCS$-10M

FCF (TTM)

GTHP$-2M

HSCS$-7M

EPS (TTM)

GTHP-$0.04

HSCS-$2.80

ROE (TTM)

GTHP-47148.0%

HSCS-35844.0%

ROA (TTM)

GTHP-24393.0%

HSCS-18198.0%

ROIC (TTM)

GTHP-37126.0%

HSCS-18863.0%

Cash

GTHP$12K

HSCS$30K

Debt

GTHP$2M

HSCS$4M

Net Cash/Debt

GTHP$-2M

HSCS$-4M

Current Ratio (TTM)

GTHP0.09x

HSCS0.14x

Quick Ratio (TTM)

GTHP0.00x

HSCS0.03x

Debt/Equity (TTM)

GTHP0.60x

HSCS16.02x

Debt/Assets (TTM)

GTHP0.0%

HSCS0.0%

Interest Coverage (TTM)

GTHPN/A

HSCSN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

HSCS0.00x

Beta

GTHP0.69

HSCS1.76

52W Performance

GTHP-20.0%

HSCS-14.5%

YTD Performance

GTHP-63.0%

HSCS1.3%

% from 52W High

GTHP-63.0%

HSCS-39.4%

% from 52W Low

GTHP66.7%

HSCS95.1%

Asset Turnover (TTM)

GTHP0.73x

HSCS0.00x

FCF Yield (TTM)

GTHP-7.8%

HSCS-57.4%

Earnings Yield (TTM)

GTHP-18.9%

HSCS-82.7%

Dividend Yield (TTM)

GTHPN/A

HSCSN/A

Rule of 40

GTHP219.2

HSCS-158,161.9

EV/GP/RG

GTHPN/A

HSCS1.64

Ticker research

View GTHP research View HSCS research

Metric	GTHP Guided Therapeutics Inc	HSCS HeartSciences Inc
Market & Valuation
Market Cap	$19M	$12M
Enterprise Value	$21M	$16M
Price	$0.20	$3.18
P/E Ratio	N/A	N/A
P/S Ratio	29.70x	2,756.00x
EV/Sales	32.92x	3,576.69x
EV/EBITDA	0.00x	0.00x
P/B Ratio	33.42x	91.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.21x	-2.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	73.69x
Revenue & Growth
Revenue (TTM)	$650K	$5K
Revenue Growth (YoY)	450.8%	-28.6%
Forward Rev Growth	0.0%	781.1%
Profitability
Gross Margin (TTM)	75.8%	60.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-210017.8%
Net Margin (TTM)	-560.6%	-227982.2%
FCF Margin (TTM)	-231.7%	-158133.3%
Net Income (TTM)	$-4M	$-10M
FCF (TTM)	$-2M	$-7M
EPS (TTM)	-$0.04	-$2.80
ROE (TTM)	-47148.0%	-35844.0%
ROA (TTM)	-24393.0%	-18198.0%
ROIC (TTM)	-37126.0%	-18863.0%
Financial Health
Cash	$12K	$30K
Debt	$2M	$4M
Net Cash/Debt	$-2M	$-4M
Current Ratio (TTM)	0.09x	0.14x
Quick Ratio (TTM)	0.00x	0.03x
Debt/Equity (TTM)	0.60x	16.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	1.76
52W Performance	-20.0%	-14.5%
YTD Performance	-63.0%	1.3%
% from 52W High	-63.0%	-39.4%
% from 52W Low	66.7%	95.1%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.00x
FCF Yield (TTM)	-7.8%	-57.4%
Earnings Yield (TTM)	-18.9%	-82.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-158,161.9
EV/GP/RG	N/A	1.64
Ticker research	View GTHP research	View HSCS research

Valuation

P/S Ratio

GTHP

29.70x

HSCS

2,756.00x

EV/FCF

GTHP

-14.21x

HSCS

-2.26x

Growth & revenue

Revenue Growth TTM

GTHP

450.8%

HSCS

-28.6%

Forward Revenue Growth

HSCS

781.1%

GTHP

0.0%

Profitability & performance

Gross Margin

GTHP

75.8%

HSCS

60.0%

ROE

HSCS

-35844.0%

GTHP

-47148.0%

FCF Yield %

GTHP

-7.8%

HSCS

-57.4%

52-Week Performance

HSCS

-14.5%

GTHP

-20.0%

Detailed metrics comparison

GTHP

Guided Therapeutics Inc

HSCS

HeartSciences Inc

Market Cap

GTHP$19M

HSCS$12M

Enterprise Value

GTHP$21M

HSCS$16M

Price

GTHP$0.20

HSCS$3.18

P/E Ratio

GTHPN/A

HSCSN/A

P/S Ratio

GTHP29.70x

HSCS2,756.00x

EV/Sales

GTHP32.92x

HSCS3,576.69x

EV/EBITDA

GTHP0.00x

HSCS0.00x

P/B Ratio

GTHP33.42x

HSCS91.31x

P/FCF Ratio

GTHPN/A

HSCSN/A

EV/FCF

GTHP-14.21x

HSCS-2.26x

PEG Ratio

GTHPN/A

HSCSN/A

Forward P/E (NTM)

GTHPN/A

HSCSN/A

Forward P/S (NTM)

GTHPN/A

HSCS73.69x

Revenue (TTM)

GTHP$650K

HSCS$5K

Revenue Growth (YoY)

GTHP450.8%

HSCS-28.6%

Forward Rev Growth

GTHP0.0%

HSCS781.1%

Gross Margin (TTM)

GTHP75.8%

HSCS60.0%

Operating Margin (TTM)

GTHP0.0%

HSCS0.0%

EBITDA Margin (TTM)

GTHP-336.2%

HSCS-210017.8%

Net Margin (TTM)

GTHP-560.6%

HSCS-227982.2%

FCF Margin (TTM)

GTHP-231.7%

HSCS-158133.3%

Net Income (TTM)

GTHP$-4M

HSCS$-10M

FCF (TTM)

GTHP$-2M

HSCS$-7M

EPS (TTM)

GTHP-$0.04

HSCS-$2.80

ROE (TTM)

GTHP-47148.0%

HSCS-35844.0%

ROA (TTM)

GTHP-24393.0%

HSCS-18198.0%

ROIC (TTM)

GTHP-37126.0%

HSCS-18863.0%

Cash

GTHP$12K

HSCS$30K

Debt

GTHP$2M

HSCS$4M

Net Cash/Debt

GTHP$-2M

HSCS$-4M

Current Ratio (TTM)

GTHP0.09x

HSCS0.14x

Quick Ratio (TTM)

GTHP0.00x

HSCS0.03x

Debt/Equity (TTM)

GTHP0.60x

HSCS16.02x

Debt/Assets (TTM)

GTHP0.0%

HSCS0.0%

Interest Coverage (TTM)

GTHPN/A

HSCSN/A

Net Debt/EBITDA (TTM)

GTHP0.00x

HSCS0.00x

Beta

GTHP0.69

HSCS1.76

52W Performance

GTHP-20.0%

HSCS-14.5%

YTD Performance

GTHP-63.0%

HSCS1.3%

% from 52W High

GTHP-63.0%

HSCS-39.4%

% from 52W Low

GTHP66.7%

HSCS95.1%

Asset Turnover (TTM)

GTHP0.73x

HSCS0.00x

FCF Yield (TTM)

GTHP-7.8%

HSCS-57.4%

Earnings Yield (TTM)

GTHP-18.9%

HSCS-82.7%

Dividend Yield (TTM)

GTHPN/A

HSCSN/A

Rule of 40

GTHP219.2

HSCS-158,161.9

EV/GP/RG

GTHPN/A

HSCS1.64

Ticker research

View GTHP research View HSCS research

Metric	GTHP Guided Therapeutics Inc	HSCS HeartSciences Inc
Market & Valuation
Market Cap	$19M	$12M
Enterprise Value	$21M	$16M
Price	$0.20	$3.18
P/E Ratio	N/A	N/A
P/S Ratio	29.70x	2,756.00x
EV/Sales	32.92x	3,576.69x
EV/EBITDA	0.00x	0.00x
P/B Ratio	33.42x	91.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.21x	-2.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	73.69x
Revenue & Growth
Revenue (TTM)	$650K	$5K
Revenue Growth (YoY)	450.8%	-28.6%
Forward Rev Growth	0.0%	781.1%
Profitability
Gross Margin (TTM)	75.8%	60.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-336.2%	-210017.8%
Net Margin (TTM)	-560.6%	-227982.2%
FCF Margin (TTM)	-231.7%	-158133.3%
Net Income (TTM)	$-4M	$-10M
FCF (TTM)	$-2M	$-7M
EPS (TTM)	-$0.04	-$2.80
ROE (TTM)	-47148.0%	-35844.0%
ROA (TTM)	-24393.0%	-18198.0%
ROIC (TTM)	-37126.0%	-18863.0%
Financial Health
Cash	$12K	$30K
Debt	$2M	$4M
Net Cash/Debt	$-2M	$-4M
Current Ratio (TTM)	0.09x	0.14x
Quick Ratio (TTM)	0.00x	0.03x
Debt/Equity (TTM)	0.60x	16.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	1.76
52W Performance	-20.0%	-14.5%
YTD Performance	-63.0%	1.3%
% from 52W High	-63.0%	-39.4%
% from 52W Low	66.7%	95.1%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.00x
FCF Yield (TTM)	-7.8%	-57.4%
Earnings Yield (TTM)	-18.9%	-82.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	219.2	-158,161.9
EV/GP/RG	N/A	1.64
Ticker research	View GTHP research	View HSCS research